These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29654716)

  • 1. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
    Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
    J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
    Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM).
    Ibrahim NS; Lazaris A; Rada M; Petrillo SK; Huck L; Hussain S; Ouladan S; Gao ZH; Gregorieff A; Essalmani R; Seidah NG; Metrakos P
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases.
    Rada M; Hassan N; Lazaris A; Metrakos P
    Front Oncol; 2022; 12():1004793. PubMed ID: 36330498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
    Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological growth pattern evolution of tumor in VX2 liver cancer model.
    Kong B; Zhou J; Wang H; Li Y; Pan Y; Zhu H; Zhang Q; Fan Q; Wang X; Zhang G
    Pathol Res Pract; 2023 Apr; 244():154401. PubMed ID: 36905696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
    Frentzas S; Simoneau E; Bridgeman VL; Vermeulen PB; Foo S; Kostaras E; Nathan M; Wotherspoon A; Gao ZH; Shi Y; Van den Eynden G; Daley F; Peckitt C; Tan X; Salman A; Lazaris A; Gazinska P; Berg TJ; Eltahir Z; Ritsma L; Van Rheenen J; Khashper A; Brown G; Nystrom H; Sund M; Van Laere S; Loyer E; Dirix L; Cunningham D; Metrakos P; Reynolds AR
    Nat Med; 2016 Nov; 22(11):1294-1302. PubMed ID: 27748747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
    Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia.
    Vermeulen PB; Colpaert C; Salgado R; Royers R; Hellemans H; Van Den Heuvel E; Goovaerts G; Dirix LY; Van Marck E
    J Pathol; 2001 Oct; 195(3):336-42. PubMed ID: 11673831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
    Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
    World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Desmoplastic Histopathological Growth Pattern for Colorectal Liver Metastases Treated With Preoperative Chemotherapy.
    Hirakawa H; Sakai H; Kanno H; Goto Y; Akashi M; Fukutomi S; Arai S; Sato T; Sudo T; Nagasu S; Miwa K; Naito Y; Akiba J; Yano H; Fujita F; Hisaka T
    Anticancer Res; 2023 Aug; 43(8):3727-3733. PubMed ID: 37500130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
    Shen Y; Wang X; Lu J; Salfenmoser M; Wirsik NM; Schleussner N; Imle A; Freire Valls A; Radhakrishnan P; Liang J; Wang G; Muley T; Schneider M; Ruiz de Almodovar C; Diz-Muñoz A; Schmidt T
    Cancer Cell; 2020 Jun; 37(6):800-817.e7. PubMed ID: 32516590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic therapies for metastatic colorectal cancer.
    Wagner AD; Arnold D; Grothey AA; Haerting J; Unverzagt S
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005392. PubMed ID: 19588372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
    Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
    J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases.
    Barnhill R; van Laere S; Vermeulen P; Roman-Roman S; Gardrat S; Alsafadi S; Tarin M; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Rodrigues M; Scolyer R; Lazar A; Romano E; Piperno-Neumann S; Mariani P; Lugassy C
    Lab Invest; 2022 Nov; 102(11):1214-1224. PubMed ID: 35672380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
    Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
    Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.